Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Atlanta Braves Holdings, Inc.BATRK · Entity 4131 | EVP, Development | December 11, 2025 | December 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Atlanta Braves Holdings, Inc.
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series C Common StockSEC Table I · non-derivative | Direct | 245,593 |
Ending reported balance
After 2025-12-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-12-11 · Exercise / conversion · Acquired 11,142 · Balance 250,467 F1: Each restricted stock unit converted into one share of Series C Common Stock. Row 2 · 2025-12-12 · Sale · Disposed 4,874 · Balance 245,593 F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F3: Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| Restricted Stock Units - BATRKSEC Table II · derivative / convertible security | Direct | 11,142 |
Reported balance
After 2025-12-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-12-11 · Exercise / conversion · Disposed 11,142 · Balance 11,142 F4: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. F5: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026. |
| Series C Common StockSEC Table I · non-derivative | IndirectBy Grantor Retained Annuity Trust | 55,503 |
Reported balance
Holding disclosure · report date 2025-12-11 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 55,503 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit converted into one share of Series C Common Stock.
F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
F3: Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
F5: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2025 Filed Dec 15, 2025 21:03 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 4,874 | $39.74 | $193,692.76 |
DisclosureSEC source: 0001104659-25-121111 · tm2533513-5_4.xml · nonDerivative · entry 2 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,593 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F3 · price: Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:03 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 11,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-121111 · tm2533513-5_4.xml · derivative · entry 4 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,142 Underlying: Series C Common Stock · 11,142 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. F5 · derivative.exercise_date: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026. F5 · derivative.expiration_date: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:03 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 11,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-121111 · tm2533513-5_4.xml · nonDerivative · entry 1 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:07 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 8,893 | $38.65 | $343,714.45 |
DisclosureSEC source: 0001104659-25-119293 · tm2532980-8_4seq1.xml · nonDerivative · entry 2 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,325 F3 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F4 · price: Reflects the weighted average sale price. The range of prices for such transaction is $38.43 to $38.81. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 21:07 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | GrantRestricted Stock Units - BATRK · Derivative | 20,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-119293 · tm2532980-8_4seq1.xml · derivative · entry 5 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,731 Underlying: Series C Common Stock · 20,731 shares Expires 2026-12-04 F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 21:07 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-119293 · tm2532980-8_4seq1.xml · derivative · entry 4 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series C Common Stock · 20,000 shares Expires 2025-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 21:07 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-119293 · tm2532980-8_4seq1.xml · nonDerivative · entry 1 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. F2 · balance_after: Reflects 22,625 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 21:09 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 69,000 | $43.00 | $2,967,000.00 |
DisclosureSEC source: 0001104659-25-059451 · tm2518029-2_4seq1.xml · nonDerivative · entry 1 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,593 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 6, 2024. F2 · price: Reflects the weighted average sale price. The range of prices for such transaction is $43.00 to $43.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 14,940 | $39.93 | $596,554.20 |
DisclosureSEC source: 0001104659-24-128471 · tm2431058-5_4seq1.xml · nonDerivative · entry 3 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,593 F3 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F4 · price: Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $39.76 to $40.26. F2 · balance_after: Reflects 21,175 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 11,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128471 · tm2431058-5_4seq1.xml · derivative · entry 6 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,284 Underlying: Series C Common Stock · 11,142 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. F6 · derivative.exercise_date: One-third of the restricted stock unit award vested on December 11, 2024, and the remaining restricted stock units vest in substantially equal installments on each of December 11, 2025 and 2026. F6 · derivative.expiration_date: One-third of the restricted stock unit award vested on December 11, 2024, and the remaining restricted stock units vest in substantially equal installments on each of December 11, 2025 and 2026. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 22,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128471 · tm2431058-5_4seq1.xml · derivative · entry 5 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series C Common Stock · 22,284 shares Expires 2024-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 11,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128471 · tm2431058-5_4seq1.xml · nonDerivative · entry 2 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. F2 · balance_after: Reflects 21,175 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 22,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128471 · tm2431058-5_4seq1.xml · nonDerivative · entry 1 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. F2 · balance_after: Reflects 21,175 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 22:03 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | GrantRestricted Stock Units - BATRK · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-126353 · tm2430393-9_4seq1.xml · derivative · entry 1 Plant Michael P. · CIK 0002036190 · EVP, Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Series C Common Stock · 20,000 shares Expires 2025-12-04 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.